← All trials
NCT07070323
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 9, 2025
- Primary completion
- Dec 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Jul 17, 2025
- Last posted
- Nov 26, 2025
- Enrollment
- 54
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- Government of ChinaSponsor investigator
- Central People's Hospital of ZhanjiangCollaborator
- People's Liberation Army of ChinaCollaborator
- Hacettepe UniversityCollaborator
- Shanghai Liquan HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.